The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.

Oral semaglutide administered via the RaniPill® HC (RT-116) demonstrated comparable bioavailability, pharmacokinetics and ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

A new nasal delivery method for amifostine could protect healthy tissue during pancreatic cancer radiation therapy, potentially improving survival and expanding treatment options. A novel approach ...

A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell.